Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Lindera obtusiloba extract

A dietary supplement composed of an ethanol extracted powder of Lindera obtusiloba, with potential antioxidant and anti-inflammatory activities. Upon administration, Lindera obtusiloba extract (LOE) may promote anti-oxidant activities through the activation of nuclear factor erythroid 2-related factor 2 (Nrf-2)/heme oxygenase 1 (HO-1)/ NAD(P)H dehydrogenase [quinone] 1 (NQO1), which reduces the production of reactive oxygen species (ROS) and lowers ROS-mediated oxidative stress. In addition, LOE may exert anti-inflammatory effects through the inhibition of the phosphorylation and activation of mitogen-activated protein kinases (MAPKs) and nuclear factor-kappa B (NF-kB).
Synonym:L. obtusiloba extract
Abbreviation:LOE
Search NCI's Drug Dictionary